Mountain Crest Acquisition Corp. V (MCAG) to Combine with CUBEBIO in $375M Deal

Mountain Crest V (NASDAQ:MCAG) has entered into a definitive agreement to combine with diagnostics biotech firm CUBEBIO for $375 million in equity compensation. Seoul, Korea-based CUBEBIO has developed 37 Korean patents around its CEED-NOVUS line of cancer screening kits. The combined company is expected to trade on the Nasdaq once the deal is completed in
Read More